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Several strains of anerobic corynebacteria, when injected into mice as killed 
vaccines, have been shown to stimulate the phagocytic activity of the mononu- 
clear phagocyte system (1, 2). The biological effects of one of these, Corynebacte- 
rium parvum, have been studied in particular and various reports indicate that 
macrophages are involved in many of the observed phenomena. These include 
stimulation of phagocytosis in vivo (3, 4), proliferation of macrophages in the 
liver (5-7),  increased resistance to infections (8-10), antitumor activity in vivo 
(reviewed in 11) and in vitro (12, 13), depression of T-cell-mediated immunologi- 
cal reactions (10,  12, 14-16), and stimulation of antibody responses (17-19). It is 
believed that macrophages participating in these various phenomena are acti- 
vated by treatment  with C. parvum,  but it is uncertain to what extent this 
activation is similar to the one described during infections with intracellular 
pathogens  (20,  21)  and particularly  whether macrophage  activation  after C. 
parvum is mediated by T lymphocytes (22-24). 
We reported recently that splenic macrophages from C. parvum-treated mice 
enhance the primary antibody response in vitro to sheep erythrocytes  (SRBC) 
(19). Here we describe results of further experiments and provide evidence that 
macrophage activation by C. parvum in this system requires T lymphocytes. 
Materials  and Methods 
Mice and Treatments.  CBA female mice between 3 and 6 mo of age were used as donors of 
spleen and peritoneal cells. Experimental mice were pretreated with a  single intravenous (i.v.) 
injection ofC. parvum suspension (batch PX 289, The Wellcome Research Laboratories, Becken- 
ham, Kent, England). Unless otherwise stated, all mice received 0.35 mg dry weight of organisms 
5 days before their cells were harvested. Control mice were untreated. 
T-cell-depleted mice were produced by thymectomy at the age of 2-3 mo, followed by lethal 
whole body irradiation  (800  R  from a  Siemens Stabilipan X-ray machine  (Siemens-Reiniger- 
Werke AG, Erlangen, W. Germany) operating at 240 kV and 10 mA, with a target distance of 50 
cm, 1 mm Cu filter, and a dose rate of 43.1 R/min) and reconstitution with 5 ×  10  ~ syngeneic bone 
marrow cells given i.v~ (TXB mice), t Control mice were not thymectomized, but were irradiated 
and reconstituted with bone marrow (XB mice). These animals were used between 30 and 60 days 
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after reconstitution. Some  TXB  mice were  additionally reconstituted with 20  ×  106 purified 
syngeneic T lymphocytes given i.v. 2 days before administration  ofC. parvum. 
In one experiment mice that had been lethally irradiated (800 R) were reconstituted with 20 x 
106 syngeneic spleen cells or purified T lymphocytes. 
Unfractionated sea Kem 9 carrageenan (REX 7220, kindly provided by Dr. D. W. Renn, Marine 
Colloids, Inc., Rockland, Maine) was dissolved in sterile saline and 1 mg was administered to mice 
intraperitoneally 7 days before their spleens were removed for use in culture. 
Mice were primed to keyhole limpet hemocyanin (KLH, Sigma Chemical Co., St. Louis, Mo.) by 
two intraperitoneal injections of 100 txg KLH and 100 Ixg ground freeze-dried  human tubercule 
bacilli in 0.2 ml Alhydrogel [Miles Seravac (Pty) Ltd., Maidenhead, Berkshire, England] given 10 
wk apart. These mice were used at least 6 wk after the second injection. 
Preparation and Fractionation of Cell Suspensions.  Spleen cell suspensions were prepared in 
RPMI 1640 medium and fractionated into nonadherent  and adherent cells as described before (19). 
Peritoneal cells were harvested by rinsing  the peritoneal cavity of untreated or C. parvum-treated 
mice with 2 ml medium. Purified T lymphocytes were prepared from spleen cell suspensions using 
a  scaled up version of the nylon wool column method (25). The cells eluted from  the column 
contained 4-6% immunoglobutin-bearing  cells compared to about 50% in unfractionated spleen 
cells  (Dr.  P.  Kilshaw, personal communication). All cell  separations were  carried out under 
aseptic conditions. 
The Antibody Response In Vitro.  Spleen cells in complete RPMI 1640 medium, containing  5% 
heat-inactivated  fetal calf serum and antibiotics (19), were cultured in Marbrook chambers (26) for 
4 days, unless otherwise stated, at 37°C in humidified air containing 5% CO2. Cultures (1 ml) 
contained 20 x 106 unfractionated  spleen cells or 13-14 x 106 nonadherent  cells recovered after the 
removal of adherent cells (19). One million viable peritoneal cells or adherent spleen cells were 
added to some cultures. The cells were cultured in the presence of either 2 × 106 SRBC or 0.1 ttg 
dinitrophenylated polymerized flagellin (DNP-POL,  kindly provided  by Dr.  M. Feldmann, De- 
partment of Zoology, University College, London, England) as antigens. Dinitrophenylated  key- 
hole limpet hemocyanin (DNP-KLH,  kindly provided by Dr. A. Boylston, Department of Experi- 
mental Pathology, St. Mary's Hospital Medical School, London, England) was added in amounts 
of 0.1-10/~g/culture. 
At the end of the culture period the cells were harvested, washed once, and resuspended in 1 ml 
medium. The antibody response to SRBC and DNP were measured in terms of direct plaque- 
forming cells (PFC) by the method of Cunningham  and Szenberg (27), using untreated SRBC and 
SRBC treated with DNP-anti-SRBC Fab fragments (28), respectively. The results are given as 
means _+ SE PFC per culture of quadruplicate cultures of cells pooled from several mice. 
Results 
The Antibody Response In Vitro of Spleen Cells from Mice Treated with C. 
parvum.  The  effect  of  varying  doses  of C.  parvum  given  to  mice  on  the 
antibody response of their spleen cells to SRBC in vitro is shown in Table I. Even 
after  the  smallest  dose  used  (0.14  mg  dry  weight  of  organisms/mouse) the 
number  of PFC  was  twice  as  high  as  in control cultures.  Larger  doses  of C. 
parvum increased the PFC response up to 3.5 times over normal responses. In 
control experiments,  not shown here,  cells from treated  mice cultured in the 
absence of SRBC gave numbers of PFC comparable to the normal background 
level (100 vs.  90). 
The  time-course  of the  in vitro  response  to  SRBC  of spleen  cells  from  C. 
parvum-treated and control mice shown in Fig.  1 indicated that the enhance- 
ment could be observed throughout the period of culture and that the maximal 
PFC response occurred at the same time in both sets of cultures. In all other 
experiments the PFC response was measured, therefore, on day 4. 
It has been reported that the time of C. parvu m administration with respect to 
immunization can affect the antibody response in vivo (29, 30) and in vitro (18), v.  s.  gldlVI~  AND  SUSAN  R.  WATSON 
TABLE  I 
Effect of Dose of C. parvum Administered to Mice on the 
Antibody Response of Spleen Cells In Vitro 
Dose of C. parvum  Response to SRBC (PFC/culture) 
mg 
0  2,010  ±  107 
0.14  4,436 ± 107 
0.175  6,550  ± 153 
0.35  6,400 ± 74 
0.70  7,060  ± 134 
1.40  7,200  ± 423 
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FIG.  1.  The time-course of the in vitro response to SRBC of spleen cells from normal (@) 
and C. parvum-treated (O) mice. 
and both enhancement and depression have been observed. The results in Fig. 2 
show that under the conditions of the present experiments the PFC response was 
enhanced when spleen cells were taken from mice between 2 h  and 21 days after 
administration  of C. parvum.  The  enhancement  of the  in  vitro response  was 
most marked 5-7 days after treatment and the interval of 5 days was selected for 
subsequent  experiments. 
In  order  to  establish  whether  the  enhancement  of  the  in  vitro  antibody 
response of spleen cells from C. parvum-treated  mice was limited to SRBC  as 
antigen,  an  experiment  was  carried  out  using  DNP-KLH,  another  T-cell-de- 
pendent antigen (31).  The results given in Table II show that normal spleen cells 
responded poorly to DNP-KLH and that to obtain a  good response the mice had 
to  have  been  primed  with  the  carrier  KLH.  Cells  from  C.  parvum-treated 
animals gave, however, a response that was greater than the response of primed 
cells. 
Effect of Carrageenan on the Antibody Response.  The effect of carrageenan, 
a polysaccharide known to be toxic to macrophages (32), but not to lymphocytes 
(33),  was  studied  in  order to  confirm the  involvement of macrophages in  the 
enhancement  of the  antibody response in vitro after administration  of C. par- 
vum.  As can be seen from Table III, a  single dose of carrageenan given 2 days 
before C. parvum  markedly reduced the antibody response to SRBC.  This was 48  ACTIVATED  MACROPHAGES  AND  THE  ANTIBODY  RESPONSE 
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FIG.  2.  The in vitro response to SRBC of spleen cells at different times after administra- 
tion of C. parvum. The shaded area represents the response of normal cells. 
TABLE  II 
The Effect of  Pretreatment with C. parvum on the In Vitro Response to 
DNP-KLH 
Source of spleen cells  Dose of DNP-KLH  PFC/culture 
Normal 
C. parvum 
KLH primed 
pg/culture 
0.1  336  ±  98 
1.0  162  ±  29 
10.0  270  ±  31 
0.1  2,506  ±  165 
1.0  3,161  ±  349 
10.0  2,212  ±  173 
0.1  1,149  ±  123 
1.0  2,131  ±  104 
10.0  1,800  ±  163 
the case with cultures containing unfractionated spleen cells as well as with 
cultures containing nonadherent cells from untreated mice and adherent spleen 
cells from animals pretreated with carrageenan. 
Requirement  for  T  Cells  in  Macrophage  Activation.  The  dependence  of 
macrophage activation by C. parvum on T lymphocytes was studied using cells 
from mice depleted of T cells by adult thymectomy and irradiation. The results 
of  two experiments using SRBC as antigen and one using DNP-POL are given in 
Table IV.  Unfractionated spleen cells from C. parvum-treated  mice gave an 
enhanced response to SRBC, but not to DNP-POL.  The response of cells from 
TXB mice to SRBC was depressed, while the response to DNP-POL was unaf- 
fected, indicating normal B-cell and defective T-cell function. Pretreatment with 
C. parvum of TXB spleen cell donors did not improve the deficient response to 
SRBC. 
An enhanced response to SRBC, although somewhat smaller than that ob- 
tained with unfractionated spleen cells, was found in cultures containing nonad- V.  S.  ~I.JIVI~  AND  SUSAN  R.  WATSON  49 
TABLE  HI 
Effect of  Pretreatment of Cell Donors with C. parvum and Carrageenan on the Antibody 
Response In Vitro 
Spleen cells in culture  Pretreatment of donors* 
Unfraction-  Nonadher-  Adherent  C. parvum  Carrageenan  ated  ent 
Response to SRBC 
(PFC/culture) 
+  ....  2,190  _+  198 
+$  -  -  5  -  4,640  _+  305 
+$  -  -  5  7  290  ___  88 
-  +  +  -  -  1,760  _+  165 
-  +  +*  5  -  3,586  _  205 
-  +  +$  -  7  396  _  69 
-  +  +$  5  7  276  _+  53 
* Days before harvesting of cells. 
$ Cells from pretreated mice. 
TABLE IV 
Lack of Enhancement of the Antibody Reponse In Vitro by Macrophages from T-Cell- 
Depleted Mice Treated with C. parvum 
Cells  in culture  PFC/culture 
Spleen 
Unfractionated  Nonadherent  Adherent 
Anti-SRBC 
Peritoneal  Anti-DNP 
cells 
Exp.  1  Exp. 2 
Normal  -  - 
CP  -  - 
TXB  -  - 
TXB-CP  -  - 
-  Normal  Normal  -  1,810  ±  27 
-  Normal  CP  -  5,396  ±  208 
-  Normal  TXB  -  1,600  ±  34 
-  Normal  TXB-CP  -  1,610  ±  58 
-  Normal  XB  - 
--  Normal  XB-CP  - 
-  Normal  Normal  2,500  ±  60 
-  Normal  CP  5,630  ±  128 
-  Normal  TXB  1,270  ±  72 
-  Normal  TXB-CP  1,460  ±  135 
Normal  XB 
-  Normal  -  XB-CP 
-  2,190  ±  89  2,200  ±  116  1,400  _+  99 
-  6,476  _+  320  4,690  -+  273  1,340  ±  83 
-  560  ±  41  1,396  _+  98 
-  666  ±  107  1,336  ±  59 
1,650  _+  101  1,526  ±  57 
3,610  +-  186  1,476  ±  106 
1,710  _+  81  1,365  ±  55 
1,666  -+ 81  1,370  ±  89 
1,760  ±  109 
2,970  ±  170 
1,746  ±  171  1,446  ±  66 
3,370  ±  170  1,280  _+  105 
1,826  ±  137  1,420  ±  77 
1,866  ±  43  1,546  ±  77 
1,740  ±  73 
3,026  ±  172 
Mice used as cell donors are designated  as follows:  normal,  untreated;  CP, C. parvum-treated. 
herent  spleen  cells  which  were  supplemented  with  either  peritoneal  cells  or 
adherent spleen cells from mice pretreated with C. parvum.  We have described 
elsewhere  (19) that in the reverse combination, i.e. normal adherent cells with 
C. parvum nonadherent cells, the response in vitro was not enhanced and have 
concluded that the enhancement is mediated by macrophages. However, when 
peritoneal or adherent spleen cells were obtained from C. parvum-treated  TXB 
mice and used to supplement normal nonadherent spleen cells no enhancement 
of the  antibody response was found  and the  numbers  of PFC  were  similar to 
cultures that were supplemented with macrophages from either normal or TXB 
mice.  On the other hand,  macrophages from XB mice treated with C. parvum 50  ACTIVATED  MACROPHAGES  AND  THE  ANTIBODY  RESPONSE 
TABLE  V 
Recovery of the Ability of Macrophages from T-Cell-Depleted Mice Reconstituted with T 
Lymphocytes to Enhance the Antibody Response In Vitro 
Cells in culture 
Spleen  Response to SRBC 
Peritoneal cells  (PFC/culture) 
Unfraction- 
Nonadhernt  Adherent  ated 
Normal  -  -  -  2,120  ±  97 
CP  -  -  -  5,986  _+ 226 
TXB  -  -  -  376 -+ 56 
TXB-CP  -  -  -  420  ±  42 
TXB-T  -  -  -  1,990  ±  95 
TXB-T-CP  -  -  -  4,750  ±  230 
Normal  Normal  -  1,710  ±  66 
Normal  CP  -  5,026  ±  128 
Normal  TXB  -  1,570  _+ 93 
Normal  TXB-CP  -  1,750  +_ 51 
Normal  TXB-T  -  1,766  ±  54 
Normal  TXB-T-CP  -  3,920  ±  72 
Normal  -  Normal  1,720  _+ 50 
Normal  -  CP  5,056  _+ 175 
Normal  -  TXB  1,350  ±  66 
Normal  -  TXB-CP  1,410  ±  87 
Normal  -  TXB-T  1,906  _+ 113 
Normal  -  TXB-T-CP  4,030  ±  210 
TXB  -  Normal  -  936  ±  90 
TXB  -  -  Normal  1,886  +_ 50 
-  TXB  Normal  -  670  _+ 48 
-  TXB  -  Normal  1,800  ±  45 
Mice used as cell donors are designated as follows: normal, untreated; CP, C. parvum-treated; T, 
reconstituted with purified T  lymphocytes. 
did  enhance  the  PFC  response  in  vitro,  although  to  a  somewhat  lesser  degree 
than  similar  cells from  normal  C. parvum-treated animals. 
Further  evidence  that  activation  of  macrophages  to  enhance  the  antibody 
response  in  vitro  requires  T  lymphocytes  was  obtained  in  the  experiment  in 
which  TXB  mice  were  reconstituted  with  purified  T  lymphocytes  2  days  before 
administration  of C.  parvum  (Table  V).  Spleen  cells  from  TXB  mice  gave  a 
much  reduced  response  to SRBC,  but  the  response  was  normal  when  cells from 
TXB  mice  reconstituted  with  T  lymphocytes  were  used.  Spleen  cells from  TXB 
mice  treated  with  C.  parvum  failed  to  show  an  enhancement  of  the  PFC 
response  in contrast  with  the  enhanced  response  of cells from  TXB  mice  recon- 
stituted  with  T  lymphocytes.  Similarly,  peritoneal  and  adherent  spleen  cells 
from C. parvum-treated normal  or TXB  mice reconstituted  with  T  cells, but  not 
from  TXB  mice,  enhanced  the  response  of normal  nonadherent  spleen  cells.  The 
results  shown  at the  bottom  of Table  V  indicate  that  normal  peritoneal  cells,  as 
opposed to adherent  spleen  cells, contained  sufficient  numbers  of T  lymphocytes V.  S.  ~LJIVI~  AND  SUSAN  R.  WATSON  51 
TABLE  VI 
Role of Recruitment and Proliferation of Macrophages During Their Activation by C. 
parvum for the Enhancement of the Antibody Responses In Vitro 
Cells in culture 
Spleen  Response to SRBC 
Peritoneal cells  (PFC/culture) 
Unfraction-  Nonadherent  Adherent  ated 
Normal  -  -  -  1,940 _+ 44 
C. parvum  -  -  -  5,390 _+ 142 
m 
n 
Normal  Normal  -  1,860 _+ 108 
Normal  CP  -  4,066 _+ 134 
Normal  X  -  11540 _+ 73 
Normal  X-CP  -  1,660 _+ 147 
Normal  X-T  -  1,846 _+ 80 
Normal  X-T-CP  -  3,676 _+ 56 
Normal  X-S  -  1,536 _+ 110 
Normal  X-S-CP  -  2,476 _+ 204 
m 
Normal  -  Normal  2,000 _+ 86 
Normal  -  CP  4,830 4- 93 
Normal  -  X  1,776 _+ 109 
Normal  -  X-CP  1,796 _+ 123 
Normal  -  X-T  1,986 _+ 163 
Normal  -  X-T-CP  2,560 _+ 172 
Normal  -  X-S  1,796 _+ 114 
Normal  -  X-S-CP  4,400 _+ 226 
Mice used as cell donors are designated as follows: normal, untreated; CP, C. parvum-treated; X, 
irradiated; T, reconstituted with purified T lymphocytes; and S, reconstituted with spleen cells. 
to  restore  the  response  of spleen  cells  from  TXB  mice  to  SRBC.  This  is  in 
agreement with the fact that T  lymphocytes are present among peritoneal cells 
(34). 
Role  of Recruitment  and  Proliferation  in  Macrophage  Activation.  It  has 
been  shown  that  C.  parvum  induces  not  only  proliferation  of macrophages 
resident in the liver, but also causes mobilization and proliferation of macro- 
phage  precursors  from  an  extra-hepatic  source  (6).  The  C.  parvum-induced 
macrophage proliferation was found to be largely responsible for the increase of 
phagocytic activity in vivo (7).  In order to determine whether T-cell-dependent 
activation of macrophages after administration of C. parvum  is dependent on 
their recruitment  and proliferation the  following experiment was  performed. 
Mice received 800 R  whole-body irradiation and within 6 h  were reconstituted 
with either purified T lymphocytes or unfractionated spleen cells. These animals 
were treated with C. parvum 2 days later and their cells were harvested 7 days 
after  irradiation.  The  adherent  spleen  cells  or  peritoneal  cells  were  used  to 
supplement nonadherent  cells from untreated  animals in culture vessels.  The 
results  showing the  PFC  response  of various cell  combinations are  given in 
Table VI. It can be seen that macrophages from irradiated mice treated with C. 
parvum failed to enhance the PFC response, but that irradiation did not alter 52  ACTIVATED  MACROPHAGES  AND  THE  ANTIBODY  RESPONSE 
the  supporting  function  of macrophages  from  otherwise  untreated  animals. 
Reconstitution  of irradiated  mice  with  purified  T  lymphocytes  restored  the 
ability  of macrophages  to  be activated  by C.  parvum.  This  restoration  was 
complete in the case of splenic macrophages and partial in the case of peritoneal 
cells.  Similar  results  were  obtained  with  cells from  mice  reconstituted  with 
spleen cells and treated with C. parvum, except that this time peritoneal cells 
enhanced the PFC response more than did adherent cells. 
Discussion 
The  observations  reported  here  confirm  recent  findings  that  the  primary 
antibody response of spleen cells to SRBC in vitro is enhanced by pretreatment 
of mice with C. parvura (18, 19). This is in agreement with several reports on the 
adjuvant activity of this organism on antibody responses in vivo to this antigen 
(17, 29, 30, 35). The in vitro response to DNP-POL, a T-cell-independent antigen 
(36) was not,  however, enhanced by pretreatment  with C. paroura.  This is in 
contrast to the findings that the in vivo response to other thymus-independent 
antigens  such as pneumococcal polysaccharide  (17) or DNP-levan  (37),  can be 
stimulated by C. parvum. The enhancement of the in vivo response to pneumo- 
coccal polysaccharide was dependent on the dose of antigen  and the time of its 
administration.  The first of these two factors did not play a role in the in vitro 
experiments,  using doses of DNP-POL from 0.01  to  10  ~g  (unpublished data), 
and the reason for the discrepancy between the two systems is not known. 
The enhancement of the in vitro response to SRBC in the present experiments 
is unique compared to other in vitro studies of adjuvant effects in which various 
materials  were active either  when added to cultures  of unprimed  spleen cells 
(38-41) or when added to cultures of cells from animals primed with the respec- 
tive material  (42, 43).  In the case of C. parvura, ceils from pretreated animals 
did not require additional exposure to the vaccine in order to give an enhanced 
response.  On the other hand,  addition of C. parvum to cultures of normal cells 
had no effect (unpublished results). 
The  present  results,  together  with  those reported earlier  (19) show clearly 
that  the  adjuvant  effect  of C.  parvura  is  mediated  by  adherent  cells.  The 
conclusion that  these cells are macrophages is supported,  in addition to their 
property of adherence, by the following observations: (a) they are radioresistant 
(19); (b) their function is suppressed after administration of carrageenan,  which 
affects  macrophages  but  not  lymphocytes  (32,  33,  44);  (c)  their  function  is 
depressed in  late  stages  of infection  with  Mycobacterium  lepraemurium,  an 
obligate intracellular  organism found in macrophages  (45); (d) peritoneal cells, 
which presumably contain more T lymphocytes (34) than adherent spleen cells, 
were not better at enhancing  the in vitro response. A  similar enhancement  of 
the antibody response to SRBC in vitro, which is also mediated by macrophages 
rather than lymphocytes, has been found using spleen cells from mice infected 
with intracellular bacteria, including M. lepraemurium,2 BCG, and Salmonella 
typhimurium  (unpublished results). 
The way in which macrophages activated by C. parvum enhance the antibody 
response to T-cell-dependent antigens is uncertain at present.  As macrophages 
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bind,  ingest,  and degrade  antigens  and present their immunogenic  moiety to 
lymphocytes involved in antibody responses (reviewed in 46) it could be postu- 
lated that such handling of antigen may be modified in activated macrophages 
and  result  in  enhanced  responses.  This  is  supported  by the  findings  on the 
handling  of KLH in vitro by peritoneal  macrophages from C. parvum-treated 
mice  (47).  The  present  observation  that  the  response  to  DNP-POL  was  not 
enhanced by C. parvum would not have contradicted this possibility in view of 
earlier reports that the in vitro response to DNP-POL is macrophage independ- 
ent  (48). It has been shown more recently, however, that in vitro responses to 
antigens, including POL, that had been considered to be macrophage independ- 
ent, require adherent accessory cells (49). If this is the case, the present finding 
would indicate that C. parvum does not modify the interaction between macro- 
phages  and  B  lymphocytes during  the  response to  DNP-POL.  In addition,  if 
antigen  handling  by macrophages is involved in the response to this antigen, 
the lack of enhancement  after C. parvum would suggest that the handling  of 
DNP-POL is not affected by C. parvum. 
Another possibility concerning the mode of action of activated macrophages in 
the enhancement  of the antibody response to SRBC is related to the findings 
that macrophage products can regulate the proliferation and function of lymph- 
oid cells in vitro  (50-52). If it is to be postulated that the enhancement  by C. 
parvum is mediated by some similar factor, this will have to act on T lympho- 
cytes,  since the  response  to  DNP-POL  was unaffected.  This  conclusion finds 
some support in the evidence that macrophages are required for the generation 
of helper T cells in vitro (53) and that factors released from macrophages are also 
active  (54). It is possible that  macrophages  activated by C. parvum  are more 
effective in the induction of helper cells in the presence of antigen, which would 
explain the lack of enhancement of the response to T-cell-independent antigens, 
such as DNP-POL.  The finding that spleen cells from C. parvum-treated mice 
gave equally good, if not better, responses to DNP-KLH, as compared to cells 
from KLH-primed animals,  provides additional  evidence that  C. parvum  can 
nonspecifically  increase  T-cell  helper  function.  It  remains  to  be  established 
whether this too is mediated via macrophages. 
As distinct from the role of T lymphocytes in the expression of the function of 
activated  macrophages,  the  present  results  show that  T  lymphocytes are  re- 
quired  for  the  activation  of macrophages  by C.  parvum.  This  is  in  general 
agreement with the requirement for T cells in the action of other adjuvants (43, 
55) and,  more specifically, with the role of T  cells in the activation  of macro- 
phages  during  the  course  of infection  with  intracellular  pathogens,  such  as 
Mycobacteria, Brucella,  Salmonella, and Listeria  (20,  21).  However, adminis- 
tration  of C.  parvum  has  been  reported  on  the  one  hand  to  suppress  cell- 
mediated reactions and T-cell function and,  on the other,  to stimulate certain 
macrophage  functions  in  the  absence  of T  lymphocytes.  Thus,  C.  parvum 
suppressed or reduced delayed hypersensitivity reactions during the course of 
Salmonella infection  (10) and after administration  of antigens in vivo (56). In 
addition, various reactions involving splenic T lymphocytes, such as the mixed 
lymphocyte and graft vs. host reactions, as well as the response to phytohemag- 
glutinin have been shown to be impaired after intravenous injections of large 54  ACTIVATED  MACROPHAGES  AND  THE  ANTIBODY  RESPONSE 
(14), but not small doses ofC. parvum  (57) and this suppression was found to be 
mediated by macrophages (15). 
Administration  of C.  parvum  by  the  subcutaneous  route  gives  rise  to  a 
significant level  of delayed hypersensitivity to  the  organism within  3  days, 
which reaches peak on day 6 (58-60). This kinetics closely parallels the enhance- 
ment of  the antibody response to SRBC in the present experiments and supports 
the view that activated macrophages which enhance this response arise through 
a  delayed hypersensitivity reaction  to  C.  parvum.  Peritoneal  cells  from C. 
parvura-treated  mice were found to be  as effective as spleen macrophages in 
enhancing the antibody response in the present  experiments. In view of the 
negligible localization of C. parvum in the peritoneal cavity after i.v. adminis- 
tration  (61) it is possible that peritoneal maerophages are  activated through 
interaction with sensitized circulating T lymphocytes. The role of T cells in the 
activation of macrophages  by  C.  parvura  is  also  illustrated by the  work  of 
Christie and Bomford (13). In their experiments activated macrophages, which 
inhibited DNA synthesis of leukemia cells,  could only be generated when C. 
parvura-sensitized,  rather than normal,  cells were cultured with C. parvura. 
The activation was  abolished by pretreatment of sensitized cells  with anti-0 
serum. However, in in vivo experiments C. parvura was almost equally effective 
in TXB and XB mice, suggesting either the stimulation of residual T cells or a 
mechanism of macrophage activation which is independent on T  lymphocytes 
(24). An apparent independence of stimulation of various macrophage functions 
on T lymphocytes has been reported using different experimental models. These 
include stimulation of phagocytic activity in T-cell-deprived mice (22), genera- 
tion of macrophages cytotoxic to tumor cells in both these and nude mice (23), 
and a relative increase in resistance to Listeria  infection in nude mice (62). It 
thus appears that certain macrophage functions can be stimulated by C. lzarvu m 
in vivo in the absence of T cells, in contrast to the present results which clearly 
indicate  that  activation  of macrophages  capable  of enhancing the  antibody 
response is T-cell dependent. 
Summary 
Splenic and peritoneal macrophages from mice treated with Corynebacterium 
parvum enhanced the antibody response in vitro of normal nonadherent spleen 
cells to SRBC, but not to DNP-POL. This enhancement was dependent on the 
dose  and  time  of administration of C.  parvum  and  could  be  abrogated  by 
pretreatment with carrageenan. Macrophages from T-cell-depleted mice failed 
to enhance the response,  but  this  ability was restored if the mice had been 
reconstituted with purified T lymphocytes. Macrophages that are activated by 
C. parvurn are a resident nondividing population. It is postulated that activated 
macrophages, capable of enhancing antibody responses to T-cell-dependent anti- 
gens, arise through a  cell-mediated reaction to C. parvum. 
We thank Dr.  P.  Kilshaw for his helpful comments on the manuscript. 
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